Safety, complications and patients' acceptance of Mohs micrographic surgery (MMS) under local anaesthesia - results from the UK MAPS (Mohs Acceptance and Patient Safety) Collaboration Group

W. Hussain (Lead / Corresponding author), A. Affleck, F. Al-Niaimi, A. Cooper, E. Craythorne, C. Fleming, V. Ghura, J. Langtry, C. Lawrence, S. Loghdey, L. Naysmith, T. Oliphant, R. Rahim, S. Rice, M. Sivaramkrishan, G. Stables, S. Varma, R. Mallipeddi

    Research output: Contribution to journalLetterpeer-review

    19 Citations (Scopus)

    Abstract

    By virtue of its tissue sparing properties and assessment of 100% of the margin of excised specimens, MMS is regarded as the gold-standard surgical treatment of high-risk non-melanoma skin cancers of the head and neck. From its original inception in the 1940s, modern day MMS has evolved to become a fresh tissue surgical technique, using frozen section margin control performed under local anaesthesia in an out-patient or day-case setting. In the UK, the increasing burden of skin cancer has resulted in a greater demand for MMS with over 32 units across the country providing the technique. This article is protected by copyright. All rights reserved.

    Original languageEnglish
    Pages (from-to)806-808
    Number of pages3
    JournalBritish Journal of Dermatology
    Volume176
    Issue number3
    Early online date5 Jul 2016
    DOIs
    Publication statusPublished - 16 Mar 2017

    Fingerprint

    Dive into the research topics of 'Safety, complications and patients' acceptance of Mohs micrographic surgery (MMS) under local anaesthesia - results from the UK MAPS (Mohs Acceptance and Patient Safety) Collaboration Group'. Together they form a unique fingerprint.

    Cite this